CTOs on the Move

ClearCorrect

www.clearcorrect.com

 
ClearCorrect works with more than 14,000 doctors, making it a leading manufacturer of clear aligners. The company offers a more affordable and doctor-friendly approach, including a phase-based system to enhance flexibility and control for doctors. It just recently celebrated its 7th year anniversary and has international plans on the horizon.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Infinity Healthcare

Infinity HealthCare ( IHC) currently provides emergency physician and radiologist staffing, using board certified and residency trained professionals, for emergency medicine and radiology departments at eighteen hospitals and regional medical centers in

Patheous Health

Patheous Health is a company that specializes in dysphagia healthcare and swallowing impairment conditions. They offer an Integrated Dysphagia Healthcare (iDH) platform and provide service solutions for both MBS and FEES studies.

Tomah Health

At Tomah Health, we are inspiring health, wellness and balance for patients, families and our community, together in care. We have been caring for our community since 1952 and Tomah Health advances excellence in care by providing quality, compassionate healthcare close to home. We are growing for you and our community to continue to provide superior healthcare for generations to come.

De Kroyft-Metz

De Kroyft-Metz is a Peoria, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fractyl Laboratories

At Fractyl, we are focused on improving the health of people with Type 2 diabetes. We`ve created an innovative clinical procedure based on new insights into the root cause of the disease. We are currently engaged in clinical trials designed to prove that our innovative procedure can dramatically improve glucose control and reduce the need for additional medications. Our mission is to set people free from the daily burdens of Type 2 diabetes management, empower physicians with a safe and reliable therapeutic treatment, and lower the tremendous human and financial costs of diabetic complications for patients, hospitals, and payers.